BeOne Secures FDA Approval for Novel Lymphoma Cell Therapy, Advancing Autoimmune Treatment Pipeline
BeOne Therapeutics has received FDA approval for its breakthrough cell therapy targeting lymphoma, marking a significant milestone in biotech innovati...